Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“Seeing is believing. The patient with multiple bone tumors after failing standard of care and complete response after just 4 doses of our targeted NK cells. And now in ongoing remission 7 months with no further treatment.
The power of NK cells is self evident. Outpatient treatment without lymphodepletion and toxic chemo. A paradigm change.”
More posts featuring Patrick Soon-Shiong.